Biocon jumps 5 percent on nod for selling product in Japan
Shares of biotechnology major Biocon today jumped by 4.75 percent after the company received approval from the Japanese health authority to sell bio-similar product 'Insulin Glargine' in the country.
Mar 28, 2016, 19:34 PM IST